Keywords: Bayer, Xarelto, Canada, Reimbursement, Yvidually, EMA arbitration, Contraceptives, Stroke prevention

Bayer's Xarelto reimbursement backed in Canada; EMA concludes Yvidually arbitration

Article | 24 April 2012

Print This

The Canadian Agency for Drugs and Technologies in Health (CADTH) through the Common Drug Review (CDR), has positively recommended to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in